Filing Details

Accession Number:
0001209191-11-061194
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-12-14 11:21:09
Reporting Period:
2011-12-12
Filing Date:
2011-12-14
Accepted Time:
2011-12-14 11:21:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1430788 D. Bryce Carmine Lilly Corporate Center
Indianapolis IN 46285
Evp And Pres, Lilly Bio-Meds No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-12-12 5,787 $39.10 51,266 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,841 Indirect 401(k)
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011.
  2. This transaction was executed in multiple trades at prices ranging from $39.06 to $39.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.